SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-25-002666
Filing Date
2025-01-10
Accepted
2025-01-10 16:20:07
Documents
13
Period of Report
2025-01-03
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0227297-8k_incannex.htm   iXBRL 8-K 31302
  Complete submission text file 0001213900-25-002666.txt   207516

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ixhl-20250103.xsd EX-101.SCH 3024
3 XBRL LABEL FILE ixhl-20250103_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ixhl-20250103_pre.xml EX-101.PRE 22365
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0227297-8k_incannex_htm.xml XML 3787
Mailing Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008
Business Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008 61 409 840 786
Incannex Healthcare Inc. (Filer) CIK: 0001873875 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41106 | Film No.: 25523241
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)